Your browser is no longer supported. Please, upgrade your browser.
Settings
NVCN Neovasc Inc. daily Stock Chart
NVCN [NASD]
Neovasc Inc.
Index- P/E- EPS (ttm)-0.17 Insider Own1.29% Shs Outstand18.97M Perf Week-20.08%
Market Cap36.98M Forward P/E- EPS next Y-0.13 Insider Trans0.00% Shs Float15.50M Perf Month-35.00%
Income- PEG- EPS next Q-0.05 Inst Own21.32% Short Float6.05% Perf Quarter-42.65%
Sales3.35M P/S11.05 EPS this Y79.70% Inst Trans- Short Ratio0.86 Perf Half Y-58.60%
Book/sh0.00 P/B- EPS next Y50.00% ROA- Target Price1.88 Perf Year-98.67%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range2.14 - 168.00 Perf YTD-96.75%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-98.84% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low-8.88% ATR0.43
Employees110 Current Ratio- Sales Q/Q-68.90% Oper. Margin- RSI (14)34.68 Volatility8.08% 16.08%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.89 Prev Close2.20
ShortableYes LT Debt/Eq- EarningsNov 13 AMC Payout- Avg Volume1.09M Price1.95
Recom1.00 SMA20-24.46% SMA50-35.54% SMA200-84.21% Volume2,252,641 Change-11.36%
Jan-19-18Resumed Canaccord Genuity Buy $1.05
Apr-05-17Upgrade Ladenburg Thalmann Neutral → Buy
May-20-16Downgrade Ladenburg Thalmann Buy → Neutral
Dec-10-15Initiated Ladenburg Thalmann Buy $9.25
Oct-07-15Resumed JMP Securities Mkt Outperform
Apr-02-15Initiated Canaccord Genuity Buy $15
Mar-31-15Initiated Northland Capital Outperform $12
Oct-22-18 04:30PM  Neovasc Announces Successful Tiara "Live Case" at the 32nd Annual EACTS 2018 Meeting PR Newswire -11.36%
Oct-16-18 07:30AM  Neovasc Announces Publication of a Peer-Reviewed Article on Tiara Cases in Circulation: Cardiovascular Interventions CNW Group
Oct-11-18 08:00AM  Todays Research Reports on Stocks to Watch: Neovasc and AcelRx Pharmaceuticals ACCESSWIRE
Oct-10-18 03:23PM  Why Neovasc Stock (NVCN) Is Skyrocketing Today InvestorPlace +14.75%
10:41AM  Neovasc's stock rockets after 'Reducer' granted Breakthrough Device designation MarketWatch
07:30AM  Neovasc Reducer Granted Breakthrough Device Designation from FDA PR Newswire
Oct-09-18 02:05PM  Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule PR Newswire -7.58%
Oct-03-18 08:28AM  Neovasc shares soar 24% on news of positive data from first U.S. patient to use device to treat angina MarketWatch +18.67%
07:30AM  Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer PR Newswire
Sep-27-18 08:43AM  Neovasc (NVCN) Looks Good: Stock Adds 7.4% in Session Zacks
Sep-24-18 08:00AM  Today's Research Reports on Trending Tickers: TransEnterix and Neovasc ACCESSWIRE
Sep-20-18 07:30AM  Neovasc's Tiara and Reducer to be Featured at TCT 2018 Conference CNW Group
Sep-19-18 10:20AM  Neovasc Announces 100th Patient to Receive Reducer Therapy in Germany PR Newswire +8.91%
Sep-18-18 06:00PM  Neovasc Announces Effective Date of Share Consolidation PR Newswire +5.56%
Sep-12-18 07:30AM  Neovasc Announces Amendments to Outstanding Convertible Notes, including 1-Year Extension of Note Maturity Date PR Newswire
07:30AM  Neovasc Announces Amendments to Outstanding Convertible Notes, including 1-Year Extension of Note Maturity Date CNW Group
Sep-11-18 07:30AM  Neovasc Announces Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule PR Newswire -15.62%
07:20AM  Neovasc Provides Initial Comments on Lawsuit CNW Group
Aug-08-18 04:48PM  Neovasc: 2Q Earnings Snapshot Associated Press +7.79%
04:05PM  Neovasc Announces Second Quarter 2018 Financial Results PR Newswire
03:19PM  What Does Neovasc Incs (TSE:NVCN) Ownership Structure Look Like? Simply Wall St.
02:30PM  Neovasc Inc. to Host Earnings Call ACCESSWIRE
01:35PM  Neovasc Announces Updated Presentation Time at the 38th Annual Canaccord Genuity Growth Conference PR Newswire
Aug-06-18 10:20AM  Biotechnology Stocks Trending on New Developments 2018 ACCESSWIRE +16.91%
07:30AM  Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology PR Newswire
07:30AM  Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology CNW Group
07:20AM  Neovasc to Present at the 38th Annual Canaccord Genuity Growth Conference PR Newswire
07:20AM  Neovasc to Present at the 38th Annual Canaccord Genuity Growth Conference CNW Group
Aug-03-18 05:34PM  Neovasc Announces Collaboration and Licensing Agreement with Penn Medicine and the Gorman Cardiovascular Research Group CNW Group
Aug-02-18 07:30AM  Neovasc Announces Second Quarter 2018 Financial Results Conference Call and Webcast CNW Group
Jul-20-18 07:00AM  Todays Free Research Reports Coverage on Neovasc and Three More Healthcare Stocks ACCESSWIRE
Jul-16-18 04:30PM  Nasdaq Schedules Hearing to Consider Neovasc's Appeal of Delisting Determination PR Newswire
04:30PM  Nasdaq Schedules Hearing to Consider Neovasc's Appeal of Delisting Determination CNW Group
07:00AM  Neovasc Announces Filing of "Administrative" Prospectus Supplement Relating to Expiry of Prior Shelf Prospectus / Registration Statement CNW Group
Jul-09-18 07:00AM  Neovasc Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing PR Newswire
Jul-02-18 07:35AM  Tiara and Reducer Featured at CSI Frankfurt 2018 CNW Group
07:30AM  Neovasc Announces Filing of Shelf Prospectus and Form F-10 Registration Statement PR Newswire
Jun-27-18 05:42AM  Should You Snap up Medical Device Stock Neovasc Now? Investopedia
Jun-21-18 04:30PM  Tiara Featured in Live Case at 11th Annual TVT 2018 PR Newswire
Jun-20-18 07:30AM  Neovasc Announces First Implant of a Neovasc Reducer in a U.S. Patient CNW Group +20.32%
Jun-18-18 07:05AM  Neovasc and Three Additional Medical Appliances & Equipment Stocks on Our Research Desks Radar ACCESSWIRE
Jun-11-18 07:30AM  Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update PR Newswire +7.84%
Jun-07-18 06:50AM  Loss-Making Neovasc Inc (NASDAQ:NVCN) Expected To Breakeven Simply Wall St.
Jun-04-18 05:38PM  Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders CNW Group +7.62%
May-25-18 07:30AM  Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer CNW Group -14.44%
May-15-18 07:30AM  Neovasc's Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock Split at the Upcoming Annual General and Special Meeting of Shareholders CNW Group -9.07%
May-11-18 08:10AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Neovasc ACCESSWIRE -18.54%
05:06AM  Neovasc: 1Q Earnings Snapshot Associated Press
May-10-18 04:05PM  Neovasc Announces Results for the First Quarter 2018 CNW Group
02:00PM  Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule CNW Group
Apr-30-18 05:26PM  Neovasc Provides a General Update, Announces Filing of Annual Report on Form 20-F and Sets First Quarter 2018 Financial Results Conference Call and Webcast CNW Group
08:20AM  Today's Research Reports on Trending Tickers: Neovasc and Puma Biotechnology ACCESSWIRE
Apr-19-18 07:10AM  Blog Exposure - NovoCure Announced Positive Top-line Results from STELLAR Trial Assessing TTFields in Mesothelioma ACCESSWIRE -5.51%
Apr-11-18 04:30PM  Neovasc Announces Receipt of US$7.1 Million from Exercise of Series C Warrants CNW Group
08:31AM  What Should We Expect From Neovasc Incs (NASDAQ:NVCN) Earnings In The Years Ahead? Simply Wall St.
Apr-06-18 08:20AM  Todays Research Reports on Trending Tickers: AVEO Pharmaceuticals and Neovasc ACCESSWIRE +48.66%
Apr-01-18 07:19AM  Was Neovasc Incs (NASDAQ:NVCN) Earnings Growth Better Than The Industrys? Simply Wall St.
Mar-28-18 04:00PM  Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 PR Newswire +7.14%
04:00PM  Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 CNW Group
12:30PM  Neovasc Inc. to Host Earnings Call ACCESSWIRE
Mar-23-18 04:30PM  Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency PR Newswire
Mar-21-18 04:30PM  Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast PR Newswire
04:30PM  Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast CNW Group
Mar-16-18 06:46AM  Is Neovasc Inc (NASDAQ:NVCN) A Buy At Its Current PE Ratio? Simply Wall St. +20.25%
Mar-13-18 08:10AM  Neovasc, Pipeline Development, Analysts Target Price, Institutional Investors ACCESSWIRE -17.67%
Feb-28-18 08:02AM  TSX Companies Insiders Are Buying Simply Wall St. +26.21%
Feb-12-18 07:00AM  Neovasc to Present at LEERINK Partners 7th Annual Global Healthcare Conference CNW Group
Feb-01-18 07:00AM  Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina PR Newswire
07:00AM  Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina CNW Group
Jan-22-18 07:00AM  Fred Colen Appointed Chief Executive Officer of Neovasc Inc. PR Newswire +23.34%
07:00AM  Fred Colen Appointed Chief Executive Officer of Neovasc Inc. CNW Group
Jan-18-18 07:00AM  Neovasc Reducer Featured in Live Case at Berlin Symposium PR Newswire
Jan-08-18 07:00AM  Neovasc Reports Tiara's Clinical Case Load Accelerating PR Newswire
07:00AM  Neovasc Reports Tiara's Clinical Case Load Accelerating CNW Group
Jan-02-18 05:00PM  Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements CNW Group
Dec-06-17 07:00AM  Neovasc Reducer Featured in Live Case at ICI 2017 CNW Group
Nov-29-17 07:59AM  Neovasc, Inc. :NVCN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-27-17 10:27AM  Neovasc to Present at the Piper Jaffray 29th Annual Healthcare Conference PR Newswire
10:27AM  Neovasc to Present at the Piper Jaffray 29th Annual Healthcare Conference CNW Group
Nov-17-17 10:02AM  Neovasc Closes Offering of Units Consisting of Common Shares and Warrants and Concurrent Private Placement of Notes and Warrants CNW Group +8.94%
Nov-16-17 09:33AM  At $0.99, Is Neovasc Inc (TSX:NVCN) A Buy? Simply Wall St.
05:14AM  Neovasc reports 3Q loss Associated Press
Nov-14-17 04:00PM  Neovasc Announces Results for the Third Quarter of 2017 PR Newswire -16.83%
04:00PM  Neovasc Announces Results for the Third Quarter of 2017 CNW Group
Nov-10-17 02:56PM  Neovasc to Host Third Quarter 2017 Conference Call PR Newswire -28.08%
02:56PM  Neovasc to Host Third Quarter 2017 Conference Call CNW Group
01:15AM  Neovasc Announces US$65 Million Underwritten Offering of Units Consisting of Common Shares and Warrants To Purchase Common Shares and Concurrent Private Placement of Notes and Warrants PR Newswire
Nov-06-17 07:00AM  Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial CNW Group +13.74%
Nov-03-17 02:44PM  Neovasc Provides Litigation Update PR Newswire -5.76%
02:44PM  Neovasc Provides Litigation Update CNW Group
Nov-02-17 09:56AM  What You Must Know About Neovasc Incs (TSX:NVCN) Major Investors Simply Wall St.
Oct-04-17 08:04AM  Dilution Ahead For Neovasc Inc (TSX:NVCN) Shareholders? Simply Wall St.
Sep-15-17 11:13AM  Why You Need To Look At This Factor Before Buying Neovasc Inc (TSX:NVCN) Simply Wall St.
Sep-12-17 07:00AM  Neovasc Provides Tiara Clinical Update CNW Group +6.90%
Sep-05-17 07:00AM  Neovasc's Reducer System Reviewed in European Heart Journal CNW Group +12.28%
Sep-01-17 12:26PM  Decision from Appeals Court upholds lower court decisions but denies injunction PR Newswire +44.30%
12:26PM  Decision from Appeals Court upholds lower court decisions but denies injunction CNW Group
10:08AM  IIROC Trade Halt - Neovasc Inc. Newsfile
Aug-25-17 10:46AM  Neovasc, Inc. :NVCN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 Capital Cube
Aug-10-17 09:55PM  Neovasc reports 2Q loss Associated Press
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.